Download | < Back |
15 Oct 2024 | |
Mark Corporate Advisors Pvt Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the eligible equity shareholders of Oxygenta Pharmaceutical Ltd ("the Company"). | |
View all announcements for Oxygenta Pharmaceutical Ltd | Source: BSE India |